Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

14 Nov 2011 07:00

RNS Number : 0002S
Kingspan Group PLC
14 November 2011
 

KINGSPAN GROUP PLC

Interim Management Statement

 

14 November 2011

 

 

Kingspan Group Plc, the leading international provider of low energy building solutions, today issues the following Interim Management Statement for the period from 1 July to 30 September 2011.

 

Business Performance

Sales in the nine months to 30 September were €1.14 billion, up 30% on prior year (up 14% excluding acquisitions), with quarter three sales up 24% (up 9% excluding acquisitions). Margins have gradually improved during the year as the earlier spikes in material increases have been recovered, combined with some easing of costs in the third quarter.

 

Our Markets

As a general comment, the strong sales growth we have experienced year to date has been driven largely by market penetration, refurbishment and geographic expansion rather than macro-economic growth in any of the Group's key markets. Furthermore, building activity in our markets globally has eased in recent months due largely to persistent economic uncertainty, particularly in the EU. This has been evident in the Group's quotation levels and order intake levels where modest reductions have been experienced during the third quarter. The Group's non-residential project pipeline however, grew slightly, which points towards positive medium term activity.

 

UK activity levels have remained resilient overall, against an uncertain economic backdrop, reflecting the wide range of end use activities of our product range. Western Europe has been solid overall and activity in Germany has remained strong, albeit with lower levels of growth than experienced earlier in the year. Eastern Europe has been challenging due to a combination of over-capacity and general economic weakness. The US construction market remains at low levels of activity overall but our Insulated Panel sales to date in that region are well ahead of last year reflecting further growth in market penetration. We continue to experience year on year growth in Australia, and activity in Ireland remains subdued at exceptionally low levels.

 

Divisional Reviews

 

Insulated Panels

Sales revenue increased by 19% in the first nine months compared to the same period last year, and was up 13% in the third quarter. In the UK and Western Europe year to date order intake was 8% and 16% ahead of last year with lower levels of growth in more recent months. In Central and Eastern Europe order intake was 7% ahead of last year with strong volumes in Germany offsetting weakness in other markets in the region. In North America year to date sales were well ahead with order intake 7% behind the comparable period last year. In summary, therefore, whilst the year to date has been characterised by strong sales growth the lower level of intake generally does point towards a lower level of sales growth in the coming months.

 

Insulation Boards

Sales revenue increased by 80% in the nine months to the end of September reflecting the acquisition of the European insulation business, with underlying sales 8% ahead year on year. Sales revenue in the third quarter was 72% ahead of last year with underlying sales, excluding the acquisition, 3% behind. Activity in the UK has been weaker since the summer with more erratic order patterns from month to month. Activity in Western Europe has been very solid overall with the acquired business now fully integrated and on plan. Australia has performed well experiencing sales growth year on year, but again that pace has eased in recent months.

 

Environmental & Renewables

Sales revenue was up 21% in the first nine months reflecting the continuation of a strong sales performance in Mainland Europe, with quarter three sales up 27%. Profitability has improved since the first half with a reduction in warranty charges and the benefit of strong continental European sales. A court decision in respect of the Borealis claim is expected in early 2012.

 

Access Floors

Sales revenue has performed resiliently in a difficult market with sales decreasing by approximately 5% overall year on year, with quarter three sales behind by 3%. New product introductions in the data centre segment have helped offset some of the weakness in the overall office market. Quotation levels are well ahead of last year which could point towards a recovery in office volumes in 2013.

 

Financial Position

Net debt at the end of September 2011 was €215.0m, a slight decrease on the amount of €216.5m reported at 30 June last, reflecting the timing of dividend and interest payments partially offsetting operating cash-flow in the period. Net debt is expected to be approximately €195m by year end.

 

Outlook

By any comparative measure of historic global activity, construction markets remain very weak with construction levels in the US and UK down approximately 50% on a 20 year average. This context is not likely to alter materially in the foreseeable future. Against this weak backdrop Kingspan has grown its sales, profits and geographic reach in the past year, driven by market penetration and conversion.

 

Should the macro environment remain stable, albeit moribund, Kingspan's product range and orientation towards energy efficient building solutions should support further gradual progress. The threat of markets retreating somewhat in 2012, however, remains a real possibility although visibility is more difficult in this environment. Given the Group's performance year to date, together with the current order-book and inquiry levels into quarter four, we expect a full year 2011 operating profit in the range of €82m-€85m, up significantly from the €67.4m achieved in 2010.

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Ed Micheau, Murray Consultants Tel: +353 (0) 1 4980300

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBCBDBGGBBGBX
Date   Source Headline
6th Jan 20215:12 pmRNSHolding(s) in Company
5th Jan 20214:03 pmRNSHolding(s) in Company
4th Jan 202110:00 amRNSBlock listing Interim Review
4th Jan 20219:00 amRNSTotal Voting Rights
17th Dec 20209:00 amRNSDirectorate Change
1st Dec 20204:12 pmRNSTotal Voting Rights
16th Nov 20207:00 amRNSTrading Statement
2nd Nov 20201:04 pmRNSDirector/PDMR Shareholding
2nd Nov 202012:19 pmRNSTotal Voting Rights
15th Oct 20205:04 pmRNSDirector/PDMR Shareholding
14th Oct 20201:05 pmRNSDirector/PDMR Shareholding
1st Oct 202012:42 pmRNSTotal Voting Rights
29th Sep 20202:32 pmRNSDirector/PDMR Shareholding
15th Sep 20207:00 amRNSGreen Private Placement
1st Sep 20203:44 pmRNSTotal Voting Rights
24th Aug 20205:34 pmRNSDirector/PDMR Shareholding
24th Aug 20205:27 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSHalf-year Report
1st Jul 20206:17 pmRNSBlock listing Interim Review
1st Jul 202011:27 amRNSTotal Voting Rights
25th Jun 20203:44 pmRNSHolding(s) in Company
17th Jun 20204:51 pmRNSHolding(s) in Company
2nd Jun 20203:00 pmRNSTotal Voting Rights
1st May 20203:20 pmRNSResult of AGM
1st May 20209:45 amRNSTotal Voting Rights
30th Apr 20207:00 amRNSTrading Statement
17th Apr 20204:11 pmRNSHolding(s) in Company
17th Apr 20207:00 amRNSStatement re AGM
14th Apr 202011:41 amRNSHolding(s) in Company
1st Apr 202012:46 pmRNSTotal Voting Rights
30th Mar 202011:37 amRNSHolding(s) in Company
23rd Mar 202011:05 amRNSHolding(s) in Company
19th Mar 202012:00 pmRNSDividend Declaration
18th Mar 20209:15 amRNSHolding(s) in Company
2nd Mar 20202:23 pmRNSTotal Voting Rights
28th Feb 202010:38 amRNSAnnual Financial Report
26th Feb 20204:54 pmRNSDirector/PDMR Shareholding
24th Feb 20205:49 pmRNSHolding(s) in Company
24th Feb 20202:26 pmRNSDirector/PDMR Shareholding
24th Feb 202010:10 amRNSDirector/PDMR Shareholding
21st Feb 20207:00 amRNSFinal Results
20th Jan 20209:50 amRNSHolding(s) in Company
3rd Jan 20205:21 pmRNSHolding(s) in Company
2nd Jan 202011:00 amRNSBlock listing Interim Review
2nd Jan 202010:00 amRNSTotal Voting Rights
17th Dec 201910:45 amRNSDirector/PDMR Shareholding
11th Dec 20195:40 pmRNSDirector/PDMR Shareholding
2nd Dec 20192:58 pmRNSTotal Voting Rights
18th Nov 20197:00 amRNSTrading Update
5th Nov 201912:43 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.